2[4]Kohne CH,Harstrick A,Hiddemann W,et al.Modulation of 5-fluorouracil with methotrexate and low-dose N-(phosphonacetyl)-L-aspartate in patients with advanced coloreotal cancer.Results of a phase Ⅱ study.Eur J Cancer,1997,33:1896-1899.
3[5]Falkson G,Gelman RS,Pandya KJ,et al.Eastern Cooperative Oncology Group randomized trials of observation versus maintenance therapy for patients with metastatic breast cancer in complete remission following induction treatment.J Clin Oncol,1998,16:1669-1676.
5[10]Geetha N,Lali VS,Hussian BM,et al.Insulin dependent diabetes mellitus induced by chemotherapy and granulocyte,macrophage-colony stimulating factor.J Assoc Physicians India,1999,47:835.
6Amercan Society of Clinical Oncology (ASCO). Clinical practice guidlelines for the treatment of unresectable nonsmall-cell lung cancer[J]. J Clin Oncol, 1997,15(9) : 2996.
7Bonomi P, Kimk,Chang A,et al. Phase Ⅲ trial comparing etopside (E) cisplation (C) vesus taxol (T) with cisplatin-G-CSF (G) versus taxol-cisplation in advanced nonsmall cell lung cancer. An Eastern Cooperative Oncology Group (ECOG) trial [abstract 1145] [J]. Proc Am Soc Clin Oncol, 1996,15 : 382.
8Giaccone G, Splinter T, Postmus P, et al. Paclitaxel-cisplatin versus teniposide-cisplation in advanced non-small cell lung cancer[abstract 1109] [J]. Proc Am Soc Clin Oncol, 1996, 15: 375.
